Stephanie Emory is Associate Director of Pharmaceutical Development at Metrics Contract Services. Dr Emory has 12 years of pharmaceutical industry experience and a strong background in product development, specifically in the field of bioavailability enhancement of small molecule formulations. She joined Metrics from the FDA where she reviewed the CMC/Drug Product portions of INDs, NDAs and industry meeting packages for CDER’s Office of Pharmaceutical Quality. Prior to the FDA, she spent seven years at UPM Pharmaceuticals, a then Baltimore-based CDMO, serving as both technical lead and project manager for the development of pre-clinical through Phase III clinical supplies. She has experience with a wide range of solid oral dosage forms and
manufacturing processes, including solubility-enhancing formulations, as well as scaleup, tech transfer and process validation activities. Dr Emory holds a Bachelor of Science in Pharmaceutical Sciences and a doctorate in Industrial & Physical Pharmacy from Purdue University (West Lafayette, IN, US).